best performing mid cap stocks 2010 to 2024

Vera Therapeutics (VERA) had the highest return between 2010 and 2024 by a mid-cap US stock, returning 16,816%.

ASSETYEARS% RETURN
Vera Therapeutics (VERA)
2010-2024
16,816%
Applied Digital (APLD)
2010-2024
6,858.11%
Novanta (NOVT)
2010-2024
5,890.98%
Patrick Industries (PATK)
2010-2024
5,559.76%
Aurinia Pharmaceuticals (AUPH)
2010-2024
5,409.2%
Nexstar Broadcasting (NXST)
2010-2024
4,984.01%
Lithia Motors (LAD)
2010-2024
4,899.65%
Saia (SAIA)
2010-2024
4,454.25%
Repligen (RGEN)
2010-2024
3,351.8%
Camtek (CAMT)
2010-2024
3,327.83%
AAON (AAON)
2010-2024
3,306.97%
IES (IESC)
2010-2024
3,306.1%
RadNet (RDNT)
2010-2024
3,257.69%
Catalyst Pharmaceuticals (CPRX)
2010-2024
3,186.61%
Axos Financial (AX)
2010-2024
2,694%
Trex (TREX)
2010-2024
2,690.44%
Kinsale Capital (KNSL)
2010-2024
2,560.75%
SPS Commerce (SPSC)
2010-2024
2,528.43%
Casella Waste Systems (CWST)
2010-2024
2,474.45%
Caesars Entertainment (CZR)
2010-2024
2,470.77%
HCI (HCI)
2010-2024
2,385.69%
Western Alliance Bancorporation (WAL)
2010-2024
2,316.99%
Kadant (KAI)
2010-2024
2,282.22%
Churchill Downs (CHDN)
2010-2024
2,258.16%
TFI International (TFII)
2010-2024
2,227.47%
Mid-cap stocks are treated as having a market cap between $2B and $10B.